
    
      Patients with irreversible pulpitis in mandibular molars will be selected according to the
      eligibility criteria and patients are then randomized to either using 0.5% bupivacaine alone
      or in addition to mannitol. Anesthetic success and postoperative pain will then be assessed.
    
  